TOMI Environmental Solutions to Showcase Decontamination Innovations at AALAS 76th National Meeting

Rhea-AI Summary

TOMI Environmental Solutions (NASDAQ: TOMZ) will participate and speak at the American Association for Laboratory Animal Science (AALAS) 76th National Meeting in Long Beach, CA, Nov 9-13, 2025. TOMI plans to showcase its SteraMist Integrated System (SIS) and ionized Hydrogen Peroxide (iHP) technology to animal research professionals, pursue distributor meetings including ARES Scientific, and highlight product integration and adoption opportunities.

The company said its executive team, led by COO Elissa J. Shane, will present to support lead generation, strategic partnerships, and expanded distribution in the animal research sector.

Unlocking Opportunities in Animal Research Sector

FREDERICK, Md., Nov. 10, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.^® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today announced its participation and speaking engagement at the American Association for Laboratory Animal Science (AALAS) 76th National Meeting, being held November 9-13, 2025, in Long Beach, California.

This premier event represents an opportunity for TOMI to connect with industry leaders, maintain strategic partnerships, and expand the reach of its groundbreaking SteraMist Integrated System (SIS) platform, positioning the company at the forefront of evolving decontamination solutions in animal research environments.

AALAS has long been a powerhouse for lead generation at TOMI, drawing thousands of professionals from research institutions and laboratories. This year's meeting offers a platform to accelerate growth through high-impact networking and collaborations. TOMI's team will engage in strategic meetings with key distributors, including ARES Scientific, to amplify distribution channels and drive further adoption of its innovative ionized Hydrogen Peroxide (iHP) technology.

Leading TOMI's presence at the event will be a powerhouse executive team, including the Chief Operating Officer, Director of Product Compliance and Manufacturing, Director of Sales, and Chief Revenue Officer. This dynamic lineup reflects TOMI's commitment to innovation and customer-centric growth.

"We're excited to showcase how our SteraMist SIS platform can integrate seamlessly with partners and customers, driving unprecedented advancements in animal research safety and efficiency,” stated Elissa J. (E.J.) Shane, TOMI’s COO. “Leveraging the AALAS platform propels our mission of delivering superior decontamination solutions worldwide. With a focus on innovation and collaboration, we are set to capitalize on the vast opportunities emerging in the animal research sector, paving the way for breakthroughs that benefit researchers, institutions, and the broader scientific community,”

TOMI™ Environmental Solutions, Inc.: Innovating for a safer world®

TOMI™ Environmental Solutions, Inc. (NASDAQ: TOMZ ) is a global decontamination and infection prevention company, providing environmental solutions for disinfection through the manufacturing, sales and licensing of its premier Binary Ionization Technology® (BIT™) platform. Invented under a defense grant in association with the Defense Advanced Research Projects Agency (DARPA) of the U.S. Department of Defense, BIT™ solution utilizes a low percentage hydrogen peroxide as its only active ingredient and uses patented ionized Hydrogen Peroxide (iHP™) technology in all SteraMist systems to create superior disinfection. TOMI products are designed to service a broad spectrum of use sites, including, but not limited to, hospitals and medical facilities, biosafety labs, pharmaceutical facilities, commercial and office buildings, schools, restaurants, meat and produce processing facilities, and police and fire departments.

For additional information, please visit http://www.steramist.com or contact us at info@tomimist.com

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

This press release contains forward-looking statements that are based on current expectations, estimates, forecasts and projections of future performance based on management’s judgment, beliefs, current trends, and anticipated product performance. These forward-looking statements include, without limitation, statements relating to TOMI’s products to serve life science sectors. Forward-looking statements involve risks and uncertainties that may cause actual results to differ materially from those contained in the forward-looking statements. These factors include, but are not limited to, our ability to maintain and manage growth and generate sales, our reliance on a single or a few products for a majority of revenues; the general business and economic conditions; and other risks as described in our SEC filings, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 filed by us with the SEC and other periodic reports we filed with the SEC. The information provided in this document is based upon the facts and circumstances known at this time. Other unknown or unpredictable factors or underlying assumptions subsequently proving to be incorrect could cause actual results to differ materially from those in the forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance, or achievements. You should not place undue reliance on these forward-looking statements. All information provided in this press release is as of today’s date, unless otherwise stated, and we undertake no duty to update such information, except as required under applicable law.

INVESTOR RELATIONS CONTACT:
John Nesbett/Rosalyn Christian
IMS Investor Relations
tomi@imsinvestorrelations.com

FAQ

When is TOMI (TOMZ) presenting at the AALAS 76th National Meeting?

TOMI is participating at AALAS Nov 9-13, 2025, with speaking engagements during the meeting.

What product will TOMI (TOMZ) showcase at AALAS 2025?

TOMI will showcase the SteraMist Integrated System (SIS) and its ionized Hydrogen Peroxide (iHP) technology.

How will TOMI use AALAS to grow distribution for TOMZ products?

TOMI plans strategic meetings with key distributors, including ARES Scientific, to amplify distribution channels and drive adoption.

Which TOMI executives will lead the company's presence at AALAS 2025?

The delegation includes the COO Elissa J. Shane, Director of Product Compliance and Manufacturing, Director of Sales, and Chief Revenue Officer.

What opportunities does TOMI expect from exhibiting at AALAS for TOMZ shareholders?

The company expects lead generation, partnership expansion, and increased product adoption in animal research markets.

Where can investors find more information about TOMI (TOMZ) products mentioned at AALAS?

Product and company information is available at the SteraMist website and via the company's investor relations contact.